Paul A Baker
Examiner (ID: 6715)
Most Active Art Unit | 2188 |
Art Unit(s) | 2188, 2187 |
Total Applications | 122 |
Issued Applications | 115 |
Pending Applications | 3 |
Abandoned Applications | 4 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18071367
[patent_doc_number] => 11530189
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Carbamate compounds and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 17/195351
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44725
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 285
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17195351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/195351 | Carbamate compounds and methods of making and using same | Mar 7, 2021 | Issued |
Array
(
[id] => 17243406
[patent_doc_number] => 20210363149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/184194
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 146890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -94
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184194
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/184194 | PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF | Feb 23, 2021 | Abandoned |
Array
(
[id] => 18369260
[patent_doc_number] => 11649415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Oil-water compositions, methods, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/177205
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8224
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177205
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/177205 | Oil-water compositions, methods, and uses thereof | Feb 16, 2021 | Issued |
Array
(
[id] => 16885359
[patent_doc_number] => 20210171554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS TO TREAT MEDICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/176962
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 379
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176962 | BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS TO TREAT MEDICAL DISORDERS | Feb 15, 2021 | Abandoned |
Array
(
[id] => 17791971
[patent_doc_number] => 20220251062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => INHIBITORS OF BACTERIAL PASTA KINASES
[patent_app_type] => utility
[patent_app_number] => 17/172314
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/172314 | Inhibitors of bacterial pasta kinases | Feb 9, 2021 | Issued |
Array
(
[id] => 17791971
[patent_doc_number] => 20220251062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => INHIBITORS OF BACTERIAL PASTA KINASES
[patent_app_type] => utility
[patent_app_number] => 17/172314
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/172314 | Inhibitors of bacterial pasta kinases | Feb 9, 2021 | Issued |
Array
(
[id] => 16854857
[patent_doc_number] => 20210155602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => TETRAHYDROQUINOLINO DERIVATIVES FOR THE TREATMENT OF METASTATIC AND CHEMORESISTANT CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/162827
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/162827 | TETRAHYDROQUINOLINO DERIVATIVES FOR THE TREATMENT OF METASTATIC AND CHEMORESISTANT CANCERS | Jan 28, 2021 | Pending |
Array
(
[id] => 19119982
[patent_doc_number] => 11963943
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Formulation for pain management
[patent_app_type] => utility
[patent_app_number] => 17/162903
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 33
[patent_no_of_words] => 18371
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162903
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/162903 | Formulation for pain management | Jan 28, 2021 | Issued |
Array
(
[id] => 16855232
[patent_doc_number] => 20210155977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => COUMARIN COMPOUNDS AND THEIR USES AS FLUORESCENT LABELS
[patent_app_type] => utility
[patent_app_number] => 17/162606
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -64
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162606
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/162606 | Coumarin compounds and their uses as fluorescent labels | Jan 28, 2021 | Issued |
Array
(
[id] => 16837820
[patent_doc_number] => 20210145832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/159674
[patent_app_country] => US
[patent_app_date] => 2021-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17159674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/159674 | TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE | Jan 26, 2021 | Abandoned |
Array
(
[id] => 17680951
[patent_doc_number] => 11365190
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Heterocyclic amides useful as protein modulators
[patent_app_type] => utility
[patent_app_number] => 17/156893
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87924
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17156893
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/156893 | Heterocyclic amides useful as protein modulators | Jan 24, 2021 | Issued |
Array
(
[id] => 17034930
[patent_doc_number] => 20210251888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => READY TO USE LIQUID FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/147953
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17147953
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/147953 | Ready to use liquid formulation | Jan 12, 2021 | Issued |
Array
(
[id] => 17036655
[patent_doc_number] => 20210253613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => PHOSPHORUS IMIDAZOQUINOLINE AMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/145300
[patent_app_country] => US
[patent_app_date] => 2021-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/145300 | Phosphorus imidazoquinoline amine derivatives, pharmaceutical compositions and therapeutic methods thereof | Jan 8, 2021 | Issued |
Array
(
[id] => 16990112
[patent_doc_number] => 20210228532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => Neurodevelopmental Disorder Therapy
[patent_app_type] => utility
[patent_app_number] => 17/145073
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145073
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/145073 | Neurodevelopmental disorder therapy | Jan 7, 2021 | Issued |
Array
(
[id] => 16807778
[patent_doc_number] => 20210130331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => COMPOUNDS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS
[patent_app_type] => utility
[patent_app_number] => 17/143409
[patent_app_country] => US
[patent_app_date] => 2021-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17143409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/143409 | Compounds for use in synthesis of peptidomimetics | Jan 6, 2021 | Issued |
Array
(
[id] => 17141602
[patent_doc_number] => 20210309614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 17/141902
[patent_app_country] => US
[patent_app_date] => 2021-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17141902
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/141902 | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | Jan 4, 2021 | Issued |
Array
(
[id] => 18028923
[patent_doc_number] => 11512096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Seco macrolide compounds
[patent_app_type] => utility
[patent_app_number] => 17/133979
[patent_app_country] => US
[patent_app_date] => 2020-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58282
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2082
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133979
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/133979 | Seco macrolide compounds | Dec 23, 2020 | Issued |
Array
(
[id] => 16762299
[patent_doc_number] => 20210107880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => FORMATION OF N-PROTECTED 3,6-BIS-(4-AMINOBUTYL)-2,5-DIKETOPIPERAZINE THROUGH A CYCLIC ALPHA-N-PROTECTED AMINO ESTER
[patent_app_type] => utility
[patent_app_number] => 17/130729
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17130729
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/130729 | Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic a-N-protected amino ester | Dec 21, 2020 | Issued |
Array
(
[id] => 16913819
[patent_doc_number] => 20210186911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => METHODS OF TREATING BRAIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/127075
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127075
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127075 | METHODS OF TREATING BRAIN DISORDERS | Dec 17, 2020 | Pending |
Array
(
[id] => 17170246
[patent_doc_number] => 20210323916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/124852
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17124852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/124852 | Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof | Dec 16, 2020 | Issued |